BARSTABLE MEDICAL CLINIC LIMITEDActive

Company number 08506284Private limited companyIncorporated 2013

Key figures

£42,767-34.8%
Net assets 2024/25
+9.5%
Average annual growth 2019/20–2024/25
050 k100 k150 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, BARSTABLE MEDICAL CLINIC LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand134,414129,448103,64840,11343,978
Total assets192,534183,119200,500131,92257,617
Total liabilities95,81075,06774,815—54,681
Net assets / total equity96,724108,052121,98665,61642,767
Average number of employees44440

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: BARSTABLE MEDICAL CLINIC LIMITED

Company

BARSTABLE MEDICAL CLINIC LIMITED is a private limited company registered with Companies House under company number 08506284. It was incorporated on 26 Apr 2013. Its status is active. The registered office is in Southend-on-sea (SS2). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files small company accounts (filleted). Net assets were £42,767, down 34.8% on the previous year. Cash at bank and in hand was £43,978. Total assets were £57,617 and total liabilities £54,681. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 10 May 2027.